| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 3.03e-06 | 16 | 131 | 4 | GO:0022858 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 6.98e-06 | 41 | 131 | 5 | GO:0015175 | |
| GeneOntologyMolecularFunction | L-alanine transmembrane transporter activity | 2.25e-05 | 9 | 131 | 3 | GO:0015180 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A18 SLC36A1 SLC25A4 SLC25A6 SLC38A5 SLC12A8 SLC39A8 SLC3A2 SLC9A4 SLC36A3 | 2.62e-05 | 296 | 131 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A18 SLC36A1 SLC25A4 PKD1L1 SLC38A5 SLC12A8 ITGAV SLC39A8 SLC3A2 SLC9A4 PIEZO2 KCNJ14 SCN7A SLC36A3 ATP1B1 | 3.09e-05 | 664 | 131 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 3.20e-05 | 10 | 131 | 3 | GO:0015187 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A18 SLC36A1 SLC25A4 PKD1L1 SLC38A5 SLC12A8 ITGAV SLC39A8 SLC3A2 SLC9A4 KCNJ14 SCN7A SLC36A3 ATP1B1 | 6.53e-05 | 627 | 131 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | aromatic amino acid transmembrane transporter activity | 7.52e-05 | 13 | 131 | 3 | GO:0015173 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC6A18 SLC36A1 SLC38A5 SLC12A8 SLC39A8 SLC3A2 SLC9A4 SLC36A3 ATP1B1 | 1.69e-04 | 301 | 131 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A18 SLC36A1 SLC25A4 PKD1L1 SLC38A5 SLC12A8 ITGAV SLC39A8 SLC3A2 SLC9A4 PIEZO2 KCNJ14 SCN7A SLC36A3 ATP1B1 | 2.23e-04 | 793 | 131 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC6A18 PKD1L1 SLC38A5 SLC12A8 ITGAV SLC39A8 SLC3A2 SLC9A4 KCNJ14 SCN7A ATP1B1 | 2.51e-04 | 465 | 131 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A18 SLC36A1 SLC25A4 SLC25A6 PKD1L1 SLC38A5 SLC12A8 ITGAV SLC2A1 SLC39A8 SLC3A2 GJA5 SLC9A4 PIEZO2 SV2B KCNJ14 SCN7A SLC36A3 ATP1B1 | 2.52e-04 | 1180 | 131 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | tRNA (cytidine-3-)-methyltransferase activity | 2.54e-04 | 4 | 131 | 2 | GO:0052735 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A18 SLC36A1 SLC25A4 SLC25A6 SLC38A5 SLC12A8 SLC39A8 SLC3A2 SLC9A4 SLC36A3 ATP1B1 | 3.11e-04 | 477 | 131 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 4.22e-04 | 5 | 131 | 2 | GO:0005471 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A18 SLC36A1 SLC25A4 PKD1L1 SLC38A5 SLC12A8 ITGAV SLC39A8 SLC3A2 SLC9A4 KCNJ14 SCN7A SLC36A3 ATP1B1 | 4.62e-04 | 758 | 131 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | alkaline phosphatase activity | 6.30e-04 | 6 | 131 | 2 | GO:0004035 | |
| GeneOntologyMolecularFunction | amino acid:proton symporter activity | 6.30e-04 | 6 | 131 | 2 | GO:0005280 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 6.43e-04 | 105 | 131 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC36A1 SLC25A4 SLC25A6 SLC38A5 SLC2A1 SLC39A8 SLC3A2 SLC36A3 | 7.12e-04 | 293 | 131 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 SLC36A1 SLC25A4 SLC25A6 PKD1L1 SLC38A5 SLC12A8 ITGAV SLC2A1 SLC39A8 SLC3A2 GJA5 SLC9A4 PIEZO2 SV2B KCNJ14 SCN7A SLC36A3 ATP1B1 | 7.49e-04 | 1289 | 131 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 8.78e-04 | 7 | 131 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 8.90e-04 | 29 | 131 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.34e-04 | 171 | 131 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.13e-03 | 119 | 131 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.22e-03 | 71 | 131 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.82e-03 | 37 | 131 | 3 | GO:0004190 | |
| GeneOntologyMolecularFunction | tRNA (cytidine) methyltransferase activity | 1.86e-03 | 10 | 131 | 2 | GO:0016427 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.97e-03 | 38 | 131 | 3 | GO:0070001 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.18e-03 | 138 | 131 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.18e-03 | 83 | 131 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 2.26e-03 | 11 | 131 | 2 | GO:0015217 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 2.81e-03 | 43 | 131 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | symporter activity | 3.12e-03 | 150 | 131 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | myosin II binding | 3.18e-03 | 13 | 131 | 2 | GO:0045159 | |
| GeneOntologyBiologicalProcess | L-alanine transport | 5.11e-07 | 11 | 132 | 4 | GO:0015808 | |
| GeneOntologyBiologicalProcess | alanine transport | 4.57e-06 | 18 | 132 | 4 | GO:0032328 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | SLC36A1 SLC38A5 SLC12A8 SLC2A1 SLC39A8 SLC3A2 SLC9A4 KCNJ14 ATP1B1 | 1.76e-05 | 230 | 132 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 4.10e-05 | 60 | 132 | 5 | GO:0015804 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 8.27e-06 | 7 | 131 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 3.83e-05 | 11 | 131 | 3 | GO:0031906 | |
| HumanPheno | Reduced left ventricular ejection fraction | 3.28e-06 | 59 | 37 | 6 | HP:0012664 | |
| HumanPheno | Abnormal echocardiogram | 3.28e-06 | 59 | 37 | 6 | HP:0003116 | |
| HumanPheno | Abnormal left ventricular ejection fraction | 3.28e-06 | 59 | 37 | 6 | HP:0034314 | |
| HumanPheno | Left ventricular systolic dysfunction | 3.61e-05 | 89 | 37 | 6 | HP:0025169 | |
| Domain | YIPPEE | 3.26e-06 | 5 | 130 | 3 | PS51792 | |
| Domain | Aspartic_peptidase_N | 1.13e-05 | 7 | 130 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 1.13e-05 | 7 | 130 | 3 | PF07966 | |
| Domain | Yippee/Mis18/Cereblon | 1.80e-05 | 8 | 130 | 3 | IPR004910 | |
| Domain | Yippee-Mis18 | 1.80e-05 | 8 | 130 | 3 | PF03226 | |
| Domain | Aspartic_peptidase_A1 | 3.82e-05 | 10 | 130 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 3.82e-05 | 10 | 130 | 3 | IPR033121 | |
| Domain | Asp | 3.82e-05 | 10 | 130 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 3.82e-05 | 10 | 130 | 3 | PS51767 | |
| Domain | - | 6.92e-05 | 12 | 130 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 6.92e-05 | 12 | 130 | 3 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 8.96e-05 | 13 | 130 | 3 | IPR001969 | |
| Domain | Disintegrin_CS | 1.73e-04 | 16 | 130 | 3 | IPR018358 | |
| Domain | Aa_trans | 2.09e-04 | 17 | 130 | 3 | PF01490 | |
| Domain | AA_transpt_TM | 2.09e-04 | 17 | 130 | 3 | IPR013057 | |
| Domain | Peptidase_aspartic_dom | 2.09e-04 | 17 | 130 | 3 | IPR021109 | |
| Domain | ADAM_CR | 2.49e-04 | 18 | 130 | 3 | PF08516 | |
| Domain | Alk_phosphatase | 2.86e-04 | 4 | 130 | 2 | PF00245 | |
| Domain | Alkaline_phosphatase_AS | 2.86e-04 | 4 | 130 | 2 | IPR018299 | |
| Domain | MeTrfase | 2.86e-04 | 4 | 130 | 2 | IPR026113 | |
| Domain | Alkaline_phosphatase | 2.86e-04 | 4 | 130 | 2 | IPR001952 | |
| Domain | alkPPc | 2.86e-04 | 4 | 130 | 2 | SM00098 | |
| Domain | ALKALINE_PHOSPHATASE | 2.86e-04 | 4 | 130 | 2 | PS00123 | |
| Domain | - | 3.44e-04 | 20 | 130 | 3 | 4.10.70.10 | |
| Domain | Disintegrin | 4.00e-04 | 21 | 130 | 3 | PF00200 | |
| Domain | DISIN | 4.00e-04 | 21 | 130 | 3 | SM00050 | |
| Domain | EGF_1 | 4.19e-04 | 255 | 130 | 8 | PS00022 | |
| Domain | - | 4.68e-04 | 52 | 130 | 4 | 2.60.120.290 | |
| Domain | CUB_dom | 6.65e-04 | 57 | 130 | 4 | IPR000859 | |
| Domain | Methyltransf_12 | 7.08e-04 | 6 | 130 | 2 | IPR013217 | |
| Domain | Methyltransf_12 | 7.08e-04 | 6 | 130 | 2 | PF08242 | |
| Domain | ADAM_Cys-rich | 8.53e-04 | 27 | 130 | 3 | IPR006586 | |
| Domain | ACR | 8.53e-04 | 27 | 130 | 3 | SM00608 | |
| Domain | PKD | 9.87e-04 | 7 | 130 | 2 | PF00801 | |
| Domain | EGF_3 | 1.30e-03 | 235 | 130 | 7 | PS50026 | |
| Domain | - | 1.52e-03 | 120 | 130 | 5 | 3.40.50.150 | |
| Domain | SAM-dependent_MTases | 1.64e-03 | 122 | 130 | 5 | IPR029063 | |
| Domain | PKD/Chitinase_dom | 1.68e-03 | 9 | 130 | 2 | IPR022409 | |
| Domain | PKD | 1.68e-03 | 9 | 130 | 2 | SM00089 | |
| Domain | EGF-like_dom | 1.81e-03 | 249 | 130 | 7 | IPR000742 | |
| Domain | EGF-like_CS | 2.36e-03 | 261 | 130 | 7 | IPR013032 | |
| Domain | Pep_M12B_propep | 2.51e-03 | 39 | 130 | 3 | PF01562 | |
| Domain | Peptidase_M12B_N | 2.51e-03 | 39 | 130 | 3 | IPR002870 | |
| Domain | - | 2.51e-03 | 39 | 130 | 3 | 2.120.10.30 | |
| Domain | PKD | 2.54e-03 | 11 | 130 | 2 | PS50093 | |
| Domain | Peptidase_S9 | 2.54e-03 | 11 | 130 | 2 | PF00326 | |
| Domain | PKD_dom | 2.54e-03 | 11 | 130 | 2 | IPR000601 | |
| Domain | Peptidase_S9 | 2.54e-03 | 11 | 130 | 2 | IPR001375 | |
| Domain | - | 2.54e-03 | 11 | 130 | 2 | 2.60.40.670 | |
| Domain | EGF_2 | 2.57e-03 | 265 | 130 | 7 | PS01186 | |
| Domain | DISINTEGRIN_1 | 2.70e-03 | 40 | 130 | 3 | PS00427 | |
| Domain | Reprolysin | 2.70e-03 | 40 | 130 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 2.70e-03 | 40 | 130 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.70e-03 | 40 | 130 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 2.70e-03 | 40 | 130 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 2.90e-03 | 41 | 130 | 3 | IPR001762 | |
| Domain | Mit_uncoupling | 3.03e-03 | 12 | 130 | 2 | IPR002030 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.02e-03 | 46 | 130 | 3 | IPR011042 | |
| Domain | CUB | 4.81e-03 | 49 | 130 | 3 | PF00431 | |
| Domain | CUB | 5.09e-03 | 50 | 130 | 3 | SM00042 | |
| Domain | Sushi | 5.68e-03 | 52 | 130 | 3 | PF00084 | |
| Domain | CUB | 5.99e-03 | 53 | 130 | 3 | PS01180 | |
| Domain | EGF | 6.08e-03 | 235 | 130 | 6 | SM00181 | |
| Domain | IGc2 | 6.08e-03 | 235 | 130 | 6 | SM00408 | |
| Domain | Ig_sub2 | 6.08e-03 | 235 | 130 | 6 | IPR003598 | |
| Domain | Aminotran_1_2 | 6.11e-03 | 17 | 130 | 2 | PF00155 | |
| Domain | Aminotransferase_I/II | 6.11e-03 | 17 | 130 | 2 | IPR004839 | |
| Domain | CCP | 6.31e-03 | 54 | 130 | 3 | SM00032 | |
| Domain | Integrin_alpha-2 | 6.84e-03 | 18 | 130 | 2 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 6.84e-03 | 18 | 130 | 2 | PS00242 | |
| Domain | Integrin_alpha2 | 6.84e-03 | 18 | 130 | 2 | PF08441 | |
| Domain | Integrin_alpha | 6.84e-03 | 18 | 130 | 2 | IPR000413 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 6.53e-05 | 11 | 106 | 3 | M39726 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 7.12e-05 | 30 | 106 | 4 | M27566 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 9.23e-05 | 32 | 106 | 4 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.04e-04 | 33 | 106 | 4 | M188 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC36A1 SLC25A4 SLC25A6 SLC38A5 SLC2A1 SLC39A8 SLC3A2 SLC9A4 | 1.07e-04 | 249 | 106 | 9 | M5988 |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 7926498 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 9561228 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 21455714 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 19800305 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 5.47e-08 | 3 | 133 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 5.47e-08 | 3 | 133 | 3 | 2799289 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 5.47e-08 | 3 | 133 | 3 | 1968039 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 5.47e-08 | 3 | 133 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 5.47e-08 | 3 | 133 | 3 | 2229438 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 5.47e-08 | 3 | 133 | 3 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 5.47e-08 | 3 | 133 | 3 | 8244094 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 21407214 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 6774973 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 5.47e-08 | 3 | 133 | 3 | 22304859 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 24004680 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 5.47e-08 | 3 | 133 | 3 | 2227273 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 23034090 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 24125879 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 5.47e-08 | 3 | 133 | 3 | 3554488 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 23521833 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 5.47e-08 | 3 | 133 | 3 | 21989121 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 9855083 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 9797498 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 2478370 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 5.47e-08 | 3 | 133 | 3 | 10675278 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 3780036 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 5.47e-08 | 3 | 133 | 3 | 3839486 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 3467902 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 5.47e-08 | 3 | 133 | 3 | 2892778 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 24383519 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 5.47e-08 | 3 | 133 | 3 | 2831884 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 2032552 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 1812762 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 7923573 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 5.47e-08 | 3 | 133 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 5.47e-08 | 3 | 133 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 5.47e-08 | 3 | 133 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 5.47e-08 | 3 | 133 | 3 | 1956484 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 8540382 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 5.47e-08 | 3 | 133 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 5.47e-08 | 3 | 133 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 5.47e-08 | 3 | 133 | 3 | 21970995 | |
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 20428942 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 9525001 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 7886402 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 17379991 | ||
| Pubmed | 5.47e-08 | 3 | 133 | 3 | 21547904 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 2.18e-07 | 4 | 133 | 3 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 2.18e-07 | 4 | 133 | 3 | 11915945 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 8322031 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 2.18e-07 | 4 | 133 | 3 | 17136346 | |
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 12698190 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 22066020 | ||
| Pubmed | 5.44e-07 | 5 | 133 | 3 | 15556292 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 5.94e-06 | 31 | 133 | 4 | 18195088 | |
| Pubmed | 6.43e-06 | 10 | 133 | 3 | 20580816 | ||
| Pubmed | Purification and partial sequencing of human placental alkaline phosphatase. | 1.45e-05 | 2 | 133 | 2 | 6651840 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 2714789 | ||
| Pubmed | Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. | 1.45e-05 | 2 | 133 | 2 | 18752324 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 11124260 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 3197840 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 3461452 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 3459156 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 1730777 | ||
| Pubmed | Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. | 1.45e-05 | 2 | 133 | 2 | 3001717 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 1.45e-05 | 2 | 133 | 2 | 24408017 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 3042787 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 12112115 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 3422741 | ||
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 1.45e-05 | 2 | 133 | 2 | 10926541 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 1939159 | ||
| Pubmed | Crystal structure of human pepsin and its complex with pepstatin. | 1.45e-05 | 2 | 133 | 2 | 7663352 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29459657 | ||
| Pubmed | Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. | 1.45e-05 | 2 | 133 | 2 | 9614495 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 2153284 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 16556444 | ||
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 1.45e-05 | 2 | 133 | 2 | 27890662 | |
| Pubmed | Molecular cloning and sequence analysis of human placental alkaline phosphatase. | 1.45e-05 | 2 | 133 | 2 | 3512548 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 2823266 | ||
| Pubmed | 4F2hc stabilizes GLUT1 protein and increases glucose transport activity. | 1.45e-05 | 2 | 133 | 2 | 21270293 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 2415509 | ||
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 1.45e-05 | 2 | 133 | 2 | 21439553 | |
| Pubmed | ARAP2 promotes GLUT1-mediated basal glucose uptake through regulation of sphingolipid metabolism. | 1.45e-05 | 2 | 133 | 2 | 27476102 | |
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 1.45e-05 | 2 | 133 | 2 | 11756613 | |
| Pubmed | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. | 1.85e-05 | 41 | 133 | 4 | 23676500 | |
| Pubmed | 2.41e-05 | 15 | 133 | 3 | 23506890 | ||
| GeneFamily | Yippee like family | 1.11e-06 | 5 | 88 | 3 | 1130 | |
| GeneFamily | Solute carriers | SLC6A18 SLC36A1 SLC25A4 SLC25A6 SLC38A5 SLC12A8 SLC2A1 SLC39A8 SLC3A2 SLC9A4 SLC36A3 | 3.34e-06 | 395 | 88 | 11 | 752 |
| GeneFamily | Methyltransferase like | 1.92e-05 | 33 | 88 | 4 | 963 | |
| GeneFamily | Alkaline phosphatases | 1.40e-04 | 4 | 88 | 2 | 1072 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.99e-04 | 27 | 88 | 3 | 47 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.70e-03 | 57 | 88 | 3 | 1179 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 3.41e-03 | 18 | 88 | 2 | 1160 | |
| ToppCell | Control-APC-like-Monocytes|Control / group, cell type (main and fine annotations) | 6.11e-07 | 163 | 133 | 7 | 4bc80a2c741d462724b6f3902377d48c57478932 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 178 | 133 | 7 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 180 | 133 | 7 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 180 | 133 | 7 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 184 | 133 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 184 | 133 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 184 | 133 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 188 | 133 | 7 | 921a2c9212a0f2a00fd72c594d80924f27e8b9b7 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 189 | 133 | 7 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 189 | 133 | 7 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.96e-06 | 194 | 133 | 7 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.24e-06 | 151 | 133 | 6 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.39e-06 | 159 | 133 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-06 | 160 | 133 | 6 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-06 | 160 | 133 | 6 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-06 | 160 | 133 | 6 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-06 | 160 | 133 | 6 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 9.67e-06 | 163 | 133 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-05 | 176 | 133 | 6 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 1.70e-05 | 180 | 133 | 6 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 181 | 133 | 6 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 181 | 133 | 6 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 181 | 133 | 6 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 133 | 6 | 812ff2a50a510b18d865e89465dba1754a08ef61 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 133 | 6 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.81e-05 | 182 | 133 | 6 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-05 | 184 | 133 | 6 | 45ff845ceed5960a997545c1009012b65e377d50 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-05 | 184 | 133 | 6 | 2cc2646dee3c6001f7c10b7449c17d1935021958 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.98e-05 | 185 | 133 | 6 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-05 | 185 | 133 | 6 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-05 | 186 | 133 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.04e-05 | 186 | 133 | 6 | 34ed60e846fd83fab3e28dc9e278bcc4b092a9f0 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 186 | 133 | 6 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.11e-05 | 187 | 133 | 6 | db771e952f71a12886c2dbc77c6cd07054ef809a | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-05 | 188 | 133 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.17e-05 | 188 | 133 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 133 | 6 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 189 | 133 | 6 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-05 | 189 | 133 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.37e-05 | 191 | 133 | 6 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.59e-05 | 194 | 133 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.59e-05 | 194 | 133 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.59e-05 | 194 | 133 | 6 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.59e-05 | 194 | 133 | 6 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.67e-05 | 195 | 133 | 6 | 4759018a7c016cb2e3df5696f1e5f912c7c9ee17 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-05 | 196 | 133 | 6 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 196 | 133 | 6 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 196 | 133 | 6 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-05 | 196 | 133 | 6 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.82e-05 | 197 | 133 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 197 | 133 | 6 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 197 | 133 | 6 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 197 | 133 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-05 | 197 | 133 | 6 | e77c91f5a1f5a292eda41abf3b1e31180f2c61e1 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 197 | 133 | 6 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | distal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-05 | 197 | 133 | 6 | 52e9dc35dd8cc2605fa4894bb16bb5c6086faa76 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.82e-05 | 197 | 133 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 2.99e-05 | 199 | 133 | 6 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.99e-05 | 199 | 133 | 6 | fb63885273d906a85fef178d859d20a311eb8a72 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.99e-05 | 199 | 133 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.99e-05 | 199 | 133 | 6 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.07e-05 | 200 | 133 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.07e-05 | 200 | 133 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 200 | 133 | 6 | a1ae299cf77580a6d1a728ee591888b6d70a19d6 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.07e-05 | 200 | 133 | 6 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.07e-05 | 200 | 133 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Esophagus_normal_tissue-Esophagus_normal_tissue|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.29e-05 | 122 | 133 | 5 | 4f091144530ac1e85f7a8296847ec08753156d71 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Esophagus_normal_tissue|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.29e-05 | 122 | 133 | 5 | 9f48ba786d913182021b3e42349fb84934b855b8 | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Esophagus_normal_tissue-Esophagus_normal_tissue-2|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.46e-05 | 130 | 133 | 5 | 3450b9edc7360f8494b5e2ded3132c508bbc971b | |
| ToppCell | TCGA-Endometrium|World / Sample_Type by Project: Shred V9 | 4.46e-05 | 130 | 133 | 5 | 101d9bf4bdf10c4f5e852067297a3bc6e735d794 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.01e-05 | 143 | 133 | 5 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 7.73e-05 | 146 | 133 | 5 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.25e-05 | 148 | 133 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.79e-05 | 150 | 133 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-05 | 153 | 133 | 5 | d5f5399ebbbff508c96ce7f01272716b61597ab5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-05 | 153 | 133 | 5 | 32cf4ca828d228f23366480305592f9813fed7ff | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.94e-05 | 154 | 133 | 5 | b0735365de153d4586ca17896431d7bd9c7d8eac | |
| ToppCell | facs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 157 | 133 | 5 | c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-04 | 158 | 133 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 159 | 133 | 5 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 160 | 133 | 5 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 160 | 133 | 5 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 160 | 133 | 5 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 161 | 133 | 5 | 6079de6cc4f2aec4091d0fac531fda9a441a70b1 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 162 | 133 | 5 | 15d5d31a75e26bcd41919a00300c68e9f00f0002 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-04 | 164 | 133 | 5 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 164 | 133 | 5 | f3772227f5aa75a3672d945f8d5bf3fa0b4e456b | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 165 | 133 | 5 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 1.37e-04 | 165 | 133 | 5 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 165 | 133 | 5 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.37e-04 | 165 | 133 | 5 | a040d18e4ba6da266440ad0b79990918770bfa7d | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.37e-04 | 165 | 133 | 5 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.41e-04 | 166 | 133 | 5 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 167 | 133 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 167 | 133 | 5 | 895844a45721988788d01120eb880603ba3ca139 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 167 | 133 | 5 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 167 | 133 | 5 | cde82e3dacf347226a78873b166608b7851b34d4 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 167 | 133 | 5 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 167 | 133 | 5 | 6f54a699d9266c5f09ed890a11b403a6c8476fc1 | |
| Computational | Neighborhood of MLF1 | 3.54e-05 | 87 | 77 | 6 | GNF2_MLF1 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.30e-06 | 197 | 132 | 9 | 3867_UP | |
| Drug | beta-hydroxypalmitoyl-CoA | 2.42e-06 | 17 | 132 | 4 | CID000440600 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 2.11e-05 | 13 | 126 | 3 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 2.11e-05 | 13 | 126 | 3 | C1261502 | |
| Disease | coffee consumption measurement, Cannabis use | 1.08e-04 | 4 | 126 | 2 | EFO_0006781, EFO_0007585 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 1.08e-04 | 4 | 126 | 2 | DOID:0111517 (implicated_via_orthology) | |
| Disease | Antiglaucoma preparations and miotics use measurement | 1.84e-04 | 26 | 126 | 3 | EFO_0009944 | |
| Disease | L lactate dehydrogenase measurement | 1.84e-04 | 26 | 126 | 3 | EFO_0004808 | |
| Disease | Stage IV Skin Melanoma | 3.75e-04 | 7 | 126 | 2 | C1321872 | |
| Disease | amyotrophic lateral sclerosis | 4.05e-04 | 145 | 126 | 5 | MONDO_0004976 | |
| Disease | childhood absence epilepsy (is_implicated_in) | 4.98e-04 | 8 | 126 | 2 | DOID:1825 (is_implicated_in) | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 6.39e-04 | 9 | 126 | 2 | C0949658 | |
| Disease | liver cancer (is_marker_for) | 6.39e-04 | 9 | 126 | 2 | DOID:3571 (is_marker_for) | |
| Disease | postburn hypertrophic scarring severity measurement | 7.96e-04 | 10 | 126 | 2 | EFO_0007747 | |
| Disease | Cardiomyopathy | 1.07e-03 | 47 | 126 | 3 | cv:C0878544 | |
| Disease | skin aging measurement | 1.10e-03 | 181 | 126 | 5 | EFO_0008006 | |
| Disease | Congenital Hypothyroidism | 1.37e-03 | 13 | 126 | 2 | C0010308 | |
| Disease | insulin metabolic clearance rate measurement, glucose homeostasis measurement | 1.59e-03 | 14 | 126 | 2 | EFO_0006830, EFO_0006896 | |
| Disease | Hypertrophic Cardiomyopathy | 1.88e-03 | 57 | 126 | 3 | C0007194 | |
| Disease | amygdala volume change measurement | 2.09e-03 | 16 | 126 | 2 | EFO_0021490 | |
| Disease | nervousness | 2.09e-03 | 16 | 126 | 2 | NCIT_C74532 | |
| Disease | theta wave measurement | 2.36e-03 | 17 | 126 | 2 | EFO_0006873 | |
| Disease | atypical femoral fracture, response to bisphosphonate | 3.11e-03 | 68 | 126 | 3 | EFO_0009958, EFO_0009960 | |
| Disease | coagulation factor V measurement | 3.27e-03 | 20 | 126 | 2 | EFO_0008087 | |
| Disease | opioid dependence | 3.56e-03 | 237 | 126 | 5 | EFO_0005611 | |
| Disease | ST2 protein measurement | 3.60e-03 | 21 | 126 | 2 | EFO_0010599 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 3.60e-03 | 21 | 126 | 2 | OBA_2045104 | |
| Disease | Arthrogryposis | 3.60e-03 | 21 | 126 | 2 | C0003886 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 3.95e-03 | 22 | 126 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | age at voice drop | 3.95e-03 | 22 | 126 | 2 | EFO_0007888 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 3.95e-03 | 22 | 126 | 2 | cv:C0949658 | |
| Disease | behavioural disinhibition measurement | 4.10e-03 | 75 | 126 | 3 | EFO_0006946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YINGNFIRGVDGSLA | 86 | Q99952 | |
| ILAGGLCVGIYATNS | 126 | Q5FVE4 | |
| LSTCFGGFQGILQIN | 116 | Q9UKF5 | |
| RRILQACGGNSLGSY | 136 | Q8TD30 | |
| REVGYCQGSAFIVGL | 191 | Q96CN4 | |
| RGLYQGFSVSVQGII | 171 | P12236 | |
| CSVAIISGGQGYRNF | 1236 | Q9HCE6 | |
| IFYGCLAGIFIGTIQ | 41 | P05026 | |
| TVVYQCNPGFRLVGT | 2701 | Q96PZ7 | |
| GSVVYQCNAGFRLIG | 2736 | Q7Z408 | |
| DGQLGLCLAYQQFRG | 376 | Q2NKJ3 | |
| GTCVRAVVIYGGTQL | 391 | Q9NQI0 | |
| ISTCRGLRGYFSQGD | 121 | Q9UKQ2 | |
| CTGLRGVLQFENVSY | 111 | Q99965 | |
| QAQKLVYLVTGGCGF | 6 | Q9H2F3 | |
| GGGQFTTIRVYFNIL | 1921 | Q6V0I7 | |
| GVCNRVTGLFPGNYV | 486 | Q8IZP0 | |
| IVNSCIAFVTQYGLG | 1131 | Q8WZ64 | |
| VGCVLDGVRYNNGQS | 121 | O95388 | |
| ATGQVLRYGQDFCLG | 136 | Q6P656 | |
| VGGSNRCSGRLEVYF | 586 | Q9NR16 | |
| NIYGSITIGQAIIFC | 331 | Q9UHL0 | |
| VYGQFTGQALLSGRE | 351 | Q06710 | |
| YILQSEGSCISGFQG | 336 | P0DJD9 | |
| AGFSCNQGRYPLIQT | 366 | Q13231 | |
| TVLRLQQYSSGGVGC | 26 | Q9H867 | |
| RVTCLYGQVQVFGFT | 141 | Q5SY16 | |
| GTCTGQLKLYNVFSG | 1111 | Q9Y4B6 | |
| YFQIVGGSNLRILGV | 376 | P43146 | |
| GVRTRGCNGLSYTLE | 51 | Q9BUE6 | |
| GCEIQTYVFLALGGT | 111 | Q8NG84 | |
| SNLQEFRYGLEGGCT | 356 | Q96A54 | |
| RFIIGVYCGLTTGFV | 126 | P11166 | |
| ITYGQCGDVLRALGQ | 71 | P08590 | |
| GIVLCGYIAGRANVI | 51 | Q7Z3F1 | |
| LGTGGFGNVCLYQHR | 21 | O15111 | |
| TALEGYQIGQVACGL | 4181 | Q15751 | |
| GETFYILIGCGFNVT | 591 | P50747 | |
| SGGDVTLQCQTRYGF | 126 | Q9HCN6 | |
| GLSGINLTTYVQPGC | 76 | Q9BYR8 | |
| GNGYISLVQCILQVF | 86 | Q9UGF5 | |
| YFIGLTVVANGGIIC | 191 | Q8NH70 | |
| TITRGGCVAQLFIYL | 91 | Q8NGV0 | |
| CGNISVNNIYGIFIV | 191 | Q9H342 | |
| LLACGVAQGALRSNY | 151 | O75594 | |
| TYRILEVGCGVGNTV | 181 | Q6P1Q9 | |
| LIYVCGGSLGNNVSG | 431 | Q8IXQ5 | |
| SINCGDSLGVYQGRV | 11 | Q96F86 | |
| YILQSEGSCISGFQG | 336 | P0DJD8 | |
| VRFVNLGGQGARYLS | 61 | Q9UNX9 | |
| TYRILEVGCGVGNTV | 181 | Q96IZ6 | |
| VLVGSYCVFSNQGGL | 146 | P56537 | |
| YLCGVKGNFQTIGLS | 121 | P05187 | |
| TAYLCGVKGNFQTIG | 116 | P10696 | |
| NYRVGVLGFLSTGDQ | 236 | Q9NZ94 | |
| GAENVGYCTQIGIFR | 216 | Q5T8I9 | |
| YQAQNFTLVCIVSGG | 161 | Q96ID5 | |
| IISVGIGDGGNYSCR | 836 | Q8N6C5 | |
| YAVGGQDGVSCLNIV | 416 | Q9Y2M5 | |
| GRIALQGTLLNTYVC | 141 | P36382 | |
| CQGYVIFVISLGSTR | 2106 | A8TX70 | |
| GIVYIFNGRSTGLNA | 401 | P06756 | |
| LLTANGQYRRTCGQG | 86 | P78396 | |
| LCGYGLTQSTVGIIG | 146 | Q9UBQ7 | |
| FYSVCGLLLQGSQGQ | 11 | Q8N3J6 | |
| TGALYRIGDLQAFQG | 221 | P08195 | |
| FGLYNERVGNLTVVG | 261 | P17174 | |
| FYIGLGSRINCNIFS | 151 | Q6PCB6 | |
| RYQLGFSVQNGIICS | 756 | Q02410 | |
| YIQLRGVQGGTLCFS | 331 | Q16739 | |
| CPLLRFSVGQTYGQV | 26 | A8MTA8 | |
| TLRVQNLGCYVVSGL | 971 | O75578 | |
| GGALLDIGIYCVQFT | 171 | Q9UQ10 | |
| LGGGLEVAISCQYRI | 146 | P40939 | |
| VGRVLQVGGRYLCIS | 146 | Q8N6R0 | |
| LAQYSLTQLCVGFNG | 391 | Q8NFF5 | |
| QLGCGRAVSALGNAY | 1926 | Q9UGM3 | |
| TIGLLYVFGQCVAGA | 121 | A0AV02 | |
| GLYGAIFRLVQASGQ | 221 | O95977 | |
| IGGVVGLNLYTCSSR | 1531 | Q8TDX9 | |
| YILQSEGSCISGFQG | 336 | P0DJD7 | |
| GYIGDSIRGAPQFCQ | 116 | Q16363 | |
| CGNIRINGIYGLFVV | 191 | Q8NH60 | |
| IGLIPYNFICVQTGS | 191 | Q96HV5 | |
| QGYGAFLFCRLISGI | 196 | Q7L1I2 | |
| QTALCGGGIQTREVY | 451 | Q9UPZ6 | |
| CEVTVGRGFGVTYQL | 36 | O76064 | |
| GRGFGVTYQLVSKIC | 41 | O76064 | |
| QAGGDVFLCLTRYIG | 416 | Q8N135 | |
| IYTFGGRILTCNGSV | 401 | Q9UL63 | |
| TCAGIAGIRAYEQLG | 101 | Q8WUX1 | |
| LGYRYLSGINVLQNC | 221 | Q5TEA6 | |
| SVQRYLQGTGCIAGL | 601 | P58107 | |
| QCIIFYSGVRGAGSF | 421 | Q6AI14 | |
| IGVSQSRLVYQGSIG | 1651 | Q9HCD6 | |
| LRLCLGSTSVGGQYG | 186 | Q8N3P4 | |
| QYACFGLFGIIALQT | 91 | O15260 | |
| LGDQRQGITSILGYC | 646 | Q7Z745 | |
| QILKGGSGTYCLNVS | 556 | P40967 | |
| LYGSNTAGYIVCRGV | 706 | Q12769 | |
| LVGGFVYRGCQSERL | 491 | Q96QV1 | |
| SIVGLLGCIFGTYQA | 436 | Q495N2 | |
| YGIVAFGNCNGLAVV | 651 | Q9Y2K9 | |
| QYLLSCTGFAVGLGN | 26 | Q96N87 | |
| AVLLVNYRGSTGFGQ | 531 | P13798 | |
| GGVGLCNTQYARLVE | 151 | P49748 | |
| RGLYQGFNVSVQGII | 171 | P12235 | |
| CLRIYLNGDGTGRGT | 391 | Q12933 | |
| GRAYLFNSVVNVGCG | 46 | O60688 | |
| LGGNISFFQSLCVLG | 141 | Q96EC8 | |
| LGCLGYLQFGANIQG | 306 | Q7Z2H8 | |
| CGQYLAAGSINGLII | 241 | O75717 | |
| ICICNYGFVGNGRTQ | 56 | Q6UWL2 | |
| IGLINLGNTCYVNSI | 441 | Q9P2H5 | |
| EVGYCQGLSFVAGIL | 886 | Q86TI0 | |
| NILSIGACGYIGTLV | 1361 | Q9H5I5 | |
| LGFTVTVGNNRGIYL | 521 | P29144 | |
| TTRCYQGKLEITGGG | 161 | Q9BY14 | |
| IQLQYGALCLNTRYG | 2666 | Q6N022 | |
| QRPYVVTFCGVNGVG | 416 | P08240 | |
| GGYTQLLQGALVCSA | 71 | Q8N661 | |
| GVYTCQAENGVGSLV | 301 | Q9BZZ2 | |
| GGSFVDACRLYVLQG | 1456 | Q14997 | |
| VGCSAVTYGVLGQAQ | 726 | Q3C1V9 | |
| GRAYLFNSVVNVGCG | 46 | Q96QA6 | |
| CGGLDARYNISVING | 186 | Q9H6L2 | |
| RGGIGAQCGLVFAYN | 591 | O43149 | |
| CVTLNTVGQLAEGGY | 11 | Q9Y2H8 | |
| CYVGLAFGILVGNNF | 376 | Q9C0K1 | |
| QVRGDCGNPSVGIFY | 1461 | Q01118 | |
| AIYCLSVSGAGLRNG | 101 | O14894 | |
| GSIQIQPSRGFYCIV | 376 | Q9BVG3 | |
| QSTGQVFLGIYLICV | 141 | Q96IK0 | |
| GRAYLFNSVVNVGCG | 46 | P61236 | |
| FDGGIYVCRATNLQG | 1246 | Q14896 | |
| QIVANYGLICVTRAG | 176 | Q9HAN9 |